Top Markets
#1 TENDIES TENDIES +53.98%
#2 Cash Cat Cash Cat +24.80%
#3 OSK OSK +15.39%
#4 龙虾 (Lobster) 龙虾 (Lobster) +11.92%
#5 Ardor Ardor +7.13%
#6 Tornado Cash Tornado Cash +6.57%
#7 UnifAI Network UnifAI Network +6.46%
#8 Zora Zora +6.31%
#9 Nesa Nesa +5.84%
#10 Talus Network Talus Network +5.47%
Coin of the day
TENDIES TENDIES
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Rang in Aktien #16737
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Aktienkurs
$2.47
Marktkapitalisierung
$269.48M
Veränderung (1 Tag)
-1.43%
Veränderung (1 Jahr)
-56.93%
Land
CN
Handel VISEN Pharmaceuticals (2561)

Kategorie

Healthcare
Preis 2561 mit Marktkapitalisierung von B
VISEN Pharmaceuticals VISEN Pharmaceuticals
2561
$2.47
Marktkapitalisierung von VISEN Pharmaceuticals(2561)
Marktkapitalisierung: $269.48M
Mit Stand September 2026 hat VISEN Pharmaceuticals eine Marktkapitalisierung von $269.48M. Das macht VISEN Pharmaceuticals laut unseren Daten zum 16737th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von VISEN Pharmaceuticals von 2025 bis 2026
2561 im Vergleich zu den Top 5 der beliebtesten stocks
Preis für 2561 Vermögenswert B Marktkapitalisierung von B Ergebnisse
VISEN Pharmaceuticals VISEN Pharmaceuticals
$48,237.65 $269.48M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +1,951,628.50%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$43,825.52 $269.48M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,773,110.67%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$36,838.88 $269.48M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,490,426.57%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$34,111.04 $269.48M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,380,056.11%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$25,076.63 $269.48M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +1,014,517.80%